Literature DB >> 14580721

The RHL-1 subunit of the asialoglycoprotein receptor of thyroid cells: cellular localization and its role in thyroglobulin endocytosis.

Francesco Pacifico1, Nunzia Montuori, Stefano Mellone, Domenico Liguoro, Luca Ulianich, Alessia Caleo, Giancarlo Troncone, Leonard D Kohn, Bruno Di Jeso, Eduardo Consiglio.   

Abstract

The rat hepatic lectin (RHL)-1 is the major component of the rat liver asialoglycoprotein receptor (ASGPr), a membrane receptor highly expressed on the basolateral side of hepatocytes, which mediates endocytosis of serum desialated glycoproteins. We have recently shown that RHL-1 is expressed in rat thyroid tissue and thyroid differentiated cell lines. Both in vitro and in vivo assays show that thyrotropin up-regulates thyroid RHL-1 expression, while neoplastic transformation of thyroid cells exerts a down-regulation of receptor expression. Moreover, RHL-1 expressed on the surface of differentiated thyroid cells is able to bind thyroglobulin (Tg), the macromolecular site of synthesis and storage of thyroid hormones. In the present work, we demonstrate, by immunohistochemistry analysis, that RHL-1 is localized on the apical surface of thyrocytes, at a variance with its basolateral localization on hepatocytes. Moreover, albeit its expression in thyroid is less abundant than in liver, the receptor is able to bind asialorosomucoid (ASOR), the best-known ligand of hepatic ASGPr, and to mediate endocytosis of a significative amount of Tg on the surface of differentiated PC Cl3 thyroid cells. Taken together, the data suggest that RHL-1, even if expressed in thyroid at lower levels than in liver, could serve as a receptor for endocytosis of colloidal Tg and, likely, for its delivery to lysosomes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14580721     DOI: 10.1016/j.mce.2003.06.001

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  6 in total

Review 1.  Intrinsic regulation of thyroid function by thyroglobulin.

Authors:  Donald F Sellitti; Koichi Suzuki
Journal:  Thyroid       Date:  2014-01-17       Impact factor: 6.568

2.  Pharmacokinetic characteristics, pharmacodynamic effect and in vivo antiviral efficacy of liver-targeted interferon alpha.

Authors:  Daniel Rycroft; Jane Sosabowski; Edward Coulstock; Marie Davies; John Morrey; Sarah Friel; Fiona Kelly; Robert Hamatake; Milan Ovečka; Rob Prince; Laura Goodall; Armin Sepp; Adam Walker
Journal:  PLoS One       Date:  2015-02-17       Impact factor: 3.240

3.  A practical protocol for carbohydrate microarrays.

Authors:  Ruobing Wang; Shaoyi Liu; Dhaval Shah; Denong Wang
Journal:  Methods Mol Biol       Date:  2005

4.  Liver-targeting of interferon-alpha with tissue-specific domain antibodies.

Authors:  Edward Coulstock; Jane Sosabowski; Milan Ovečka; Rob Prince; Laura Goodall; Clare Mudd; Armin Sepp; Marie Davies; Julie Foster; Jerome Burnet; Gráinne Dunlevy; Adam Walker
Journal:  PLoS One       Date:  2013-02-25       Impact factor: 3.240

Review 5.  Glycosylation in the Thyroid Gland: Vital Aspects of Glycoprotein Function in Thyrocyte Physiology and Thyroid Disorders.

Authors:  Marta Ząbczyńska; Kamila Kozłowska; Ewa Pocheć
Journal:  Int J Mol Sci       Date:  2018-09-17       Impact factor: 5.923

6.  Glycan arrays lead to the discovery of autoimmunogenic activity of SARS-CoV.

Authors:  Denong Wang; Jiahai Lu
Journal:  Physiol Genomics       Date:  2004-07-08       Impact factor: 3.107

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.